sales@marketresearchvision.com

30 mins free consultation for each report        Upto 50% Discounts for Highest selling reports


COVID-19 Impact on Global Kidney Cancer Drug Market Size, Status and Forecast 2020-2026

COVID-19 Impact on Global Kidney Cancer Drug Market Size, Status and Forecast 2020-2026

Category : Pharmaceuticals and Healthcare QY Research Pages :128
Published Date : 2020-09-16

 

Covid-19

COVID-19

Understand the influence of COVID-19 on the Kidney Cancer Drug Market with our analysts monitoring the situation across the globe.
This report focuses on the global Kidney Cancer Drug status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Kidney Cancer Drug development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America. The key players covered in this study Active Biotech Amgen Bayer AG Cipla Limited F. Hoffmann-La Roche Genentech Glaxosmithkline PLC Novartis AG Onyx Pharmaceuticals Pfizer Abbott Laboratories Aveo Pharmaceuticals Immatics Biotechnologies Prometheus Laboratories Exelixis Market segment by Type, the product can be split into Nexavar (Sorafenib) Sutent (Sunitinib) Afinitor (Everolimus) Votrient (Pazopanib) Avastin (Bevacizumab) Inlyta (Axitinib) Torisel (Temsirolimus) Proleukin (Aldesleukin) Other Market segment by Application, split into Hospitals Clinics Research Center Other Market segment by Regions/Countries, this report covers North America Europe China Japan Southeast Asia India Central & South America The study objectives of this report are: To analyze global Kidney Cancer Drug status, future forecast, growth opportunity, key market and key players. To present the Kidney Cancer Drug development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America. To strategically profile the key players and comprehensively analyze their development plan and strategies. To define, describe and forecast the market by type, market and key regions. In this study, the years considered to estimate the market size of Kidney Cancer Drug are as follows: History Year: 2015-2019 Base Year: 2019 Estimated Year: 2020 Forecast Year 2020 to 2026 For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered: Ranking by Kidney Cancer Drug Revenue 1.4 Market Analysis by Type 1.4.1 Global Kidney Cancer Drug Market Size Growth Rate by Type: 2020 VS 2026 1.4.2 Nexavar (Sorafenib) 1.4.3 Sutent (Sunitinib) 1.4.4 Afinitor (Everolimus) 1.4.5 Votrient (Pazopanib) 1.4.6 Avastin (Bevacizumab) 1.4.7 Inlyta (Axitinib) 1.4.8 Torisel (Temsirolimus) 1.4.9 Proleukin (Aldesleukin) 1.4.10 Other 1.5 Market by Application 1.5.1 Global Kidney Cancer Drug Market Share by Application: 2020 VS 2026 1.5.2 Hospitals 1.5.3 Clinics 1.5.4 Research Center 1.5.5 Other 1.6 Coronavirus Disease 2019 (Covid-19): Kidney Cancer Drug Industry Impact 1.6.1 How the Covid-19 is Affecting the Kidney Cancer Drug Industry 1.6.1.1 Kidney Cancer Drug Business Impact Assessment - Covid-19 1.6.1.2 Supply Chain Challenges 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products 1.6.2 Market Trends and Kidney Cancer Drug Potential Opportunities in the COVID-19 Landscape 1.6.3 Measures / Proposal against Covid-19 1.6.3.1 Government Measures to Combat Covid-19 Impact 1.6.3.2 Proposal for Kidney Cancer Drug Players to Combat Covid-19 Impact 1.7 Study Objectives 1.8 Years Considered 2 Global Growth Trends by Regions 2.1 Kidney Cancer Drug Market Perspective (2015-2026) 2.2 Kidney Cancer Drug Growth Trends by Regions 2.2.1 Kidney Cancer Drug Market Size by Regions: 2015 VS 2020 VS 2026 2.2.2 Kidney Cancer Drug Historic Market Share by Regions (2015-2020) 2.2.3 Kidney Cancer Drug Forecasted Market Size by Regions (2021-2026) 2.3 Industry Trends and Growth Strategy 2.3.1 Market Top Trends 2.3.2 Market Drivers 2.3.3 Market Challenges 2.3.4 Porter’s Five Forces Analysis 2.3.5 Kidney Cancer Drug Market Growth Strategy 2.3.6 Primary Interviews with Key Kidney Cancer Drug Players (Opinion Leaders) 3 Competition Landscape by Key Players 3.1 Global Top Kidney Cancer Drug Players by Market Size 3.1.1 Global Top Kidney Cancer Drug Players by Revenue (2015-2020) 3.1.2 Global Kidney Cancer Drug Revenue Market Share by Players (2015-2020) 3.1.3 Global Kidney Cancer Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.2 Global Kidney Cancer Drug Market Concentration Ratio 3.2.1 Global Kidney Cancer Drug Market Concentration Ratio (CR5 and HHI) 3.2.2 Global Top 10 and Top 5 Companies by Kidney Cancer Drug Revenue in 2019 3.3 Kidney Cancer Drug Key Players Head office and Area Served 3.4 Key Players Kidney Cancer Drug Product Solution and Service 3.5 Date of Enter into Kidney Cancer Drug Market 3.6 Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type (2015-2026) 4.1 Global Kidney Cancer Drug Historic Market Size by Type (2015-2020) 4.2 Global Kidney Cancer Drug Forecasted Market Size by Type (2021-2026) 5 Kidney Cancer Drug Breakdown Data by Application (2015-2026) 5.1 Global Kidney Cancer Drug Market Size by Application (2015-2020) 5.2 Global Kidney Cancer Drug Forecasted Market Size by Application (2021-2026) 6 North America 6.1 North America Kidney Cancer Drug Market Size (2015-2020) 6.2 Kidney Cancer Drug Key Players in North America (2019-2020) 6.3 North America Kidney Cancer Drug Market Size by Type (2015-2020) 6.4 North America Kidney Cancer Drug Market Size by Application (2015-2020) 7 Europe 7.1 Europe Kidney Cancer Drug Market Size (2015-2020) 7.2 Kidney Cancer Drug Key Players in Europe (2019-2020) 7.3 Europe Kidney Cancer Drug Market Size by Type (2015-2020) 7.4 Europe Kidney Cancer Drug Market Size by Application (2015-2020) 8 China 8.1 China Kidney Cancer Drug Market Size (2015-2020) 8.2 Kidney Cancer Drug Key Players in China (2019-2020) 8.3 China Kidney Cancer Drug Market Size by Type (2015-2020) 8.4 China Kidney Cancer Drug Market Size by Application (2015-2020) 9 Japan 9.1 Japan Kidney Cancer Drug Market Size (2015-2020) 9.2 Kidney Cancer Drug Key Players in Japan (2019-2020) 9.3 Japan Kidney Cancer Drug Market Size by Type (2015-2020) 9.4 Japan Kidney Cancer Drug Market Size by Application (2015-2020) 10 Southeast Asia 10.1 Southeast Asia Kidney Cancer Drug Market Size (2015-2020) 10.2 Kidney Cancer Drug Key Players in Southeast Asia (2019-2020) 10.3 Southeast Asia Kidney Cancer Drug Market Size by Type (2015-2020) 10.4 Southeast Asia Kidney Cancer Drug Market Size by Application (2015-2020) 11 India 11.1 India Kidney Cancer Drug Market Size (2015-2020) 11.2 Kidney Cancer Drug Key Players in India (2019-2020) 11.3 India Kidney Cancer Drug Market Size by Type (2015-2020) 11.4 India Kidney Cancer Drug Market Size by Application (2015-2020) 12 Central & South America 12.1 Central & South America Kidney Cancer Drug Market Size (2015-2020) 12.2 Kidney Cancer Drug Key Players in Central & South America (2019-2020) 12.3 Central & South America Kidney Cancer Drug Market Size by Type (2015-2020) 12.4 Central & South America Kidney Cancer Drug Market Size by Application (2015-2020) 13 Key Players Profiles 13.1 Active Biotech 13.1.1 Active Biotech Company Details 13.1.2 Active Biotech Business Overview and Its Total Revenue 13.1.3 Active Biotech Kidney Cancer Drug Introduction 13.1.4 Active Biotech Revenue in Kidney Cancer Drug Business (2015-2020)) 13.1.5 Active Biotech Recent Development 13.2 Amgen 13.2.1 Amgen Company Details 13.2.2 Amgen Business Overview and Its Total Revenue 13.2.3 Amgen Kidney Cancer Drug Introduction 13.2.4 Amgen Revenue in Kidney Cancer Drug Business (2015-2020) 13.2.5 Amgen Recent Development 13.3 Bayer AG 13.3.1 Bayer AG Company Details 13.3.2 Bayer AG Business Overview and Its Total Revenue 13.3.3 Bayer AG Kidney Cancer Drug Introduction 13.3.4 Bayer AG Revenue in Kidney Cancer Drug Business (2015-2020) 13.3.5 Bayer AG Recent Development 13.4 Cipla Limited 13.4.1 Cipla Limited Company Details 13.4.2 Cipla Limited Business Overview and Its Total Revenue 13.4.3 Cipla Limited Kidney Cancer Drug Introduction 13.4.4 Cipla Limited Revenue in Kidney Cancer Drug Business (2015-2020) 13.4.5 Cipla Limited Recent Development 13.5 F. Hoffmann-La Roche 13.5.1 F. Hoffmann-La Roche Company Details 13.5.2 F. Hoffmann-La Roche Business Overview and Its Total Revenue 13.5.3 F. Hoffmann-La Roche Kidney Cancer Drug Introduction 13.5.4 F. Hoffmann-La Roche Revenue in Kidney Cancer Drug Business (2015-2020) 13.5.5 F. Hoffmann-La Roche Recent Development 13.6 Genentech 13.6.1 Genentech Company Details 13.6.2 Genentech Business Overview and Its Total Revenue 13.6.3 Genentech Kidney Cancer Drug Introduction 13.6.4 Genentech Revenue in Kidney Cancer Drug Business (2015-2020) 13.6.5 Genentech Recent Development 13.7 Glaxosmithkline PLC 13.7.1 Glaxosmithkline PLC Company Details 13.7.2 Glaxosmithkline PLC Business Overview and Its Total Revenue 13.7.3 Glaxosmithkline PLC Kidney Cancer Drug Introduction 13.7.4 Glaxosmithkline PLC Revenue in Kidney Cancer Drug Business (2015-2020) 13.7.5 Glaxosmithkline PLC Recent Development 13.8 Novartis AG 13.8.1 Novartis AG Company Details 13.8.2 Novartis AG Business Overview and Its Total Revenue 13.8.3 Novartis AG Kidney Cancer Drug Introduction 13.8.4 Novartis AG Revenue in Kidney Cancer Drug Business (2015-2020) 13.8.5 Novartis AG Recent Development 13.9 Onyx Pharmaceuticals 13.9.1 Onyx Pharmaceuticals Company Details 13.9.2 Onyx Pharmaceuticals Business Overview and Its Total Revenue 13.9.3 Onyx Pharmaceuticals Kidney Cancer Drug Introduction 13.9.4 Onyx Pharmaceuticals Revenue in Kidney Cancer Drug Business (2015-2020) 13.9.5 Onyx Pharmaceuticals Recent Development 13.10 Pfizer 13.10.1 Pfizer Company Details 13.10.2 Pfizer Business Overview and Its Total Revenue 13.10.3 Pfizer Kidney Cancer Drug Introduction 13.10.4 Pfizer Revenue in Kidney Cancer Drug Business (2015-2020) 13.10.5 Pfizer Recent Development 13.11 Abbott Laboratories 10.11.1 Abbott Laboratories Company Details 10.11.2 Abbott Laboratories Business Overview and Its Total Revenue 10.11.3 Abbott Laboratories Kidney Cancer Drug Introduction 10.11.4 Abbott Laboratories Revenue in Kidney Cancer Drug Business (2015-2020) 10.11.5 Abbott Laboratories Recent Development 13.12 Aveo Pharmaceuticals 10.12.1 Aveo Pharmaceuticals Company Details 10.12.2 Aveo Pharmaceuticals Business Overview and Its Total Revenue 10.12.3 Aveo Pharmaceuticals Kidney Cancer Drug Introduction 10.12.4 Aveo Pharmaceuticals Revenue in Kidney Cancer Drug Business (2015-2020) 10.12.5 Aveo Pharmaceuticals Recent Development 13.13 Immatics Biotechnologies 10.13.1 Immatics Biotechnologies Company Details 10.13.2 Immatics Biotechnologies Business Overview and Its Total Revenue 10.13.3 Immatics Biotechnologies Kidney Cancer Drug Introduction 10.13.4 Immatics Biotechnologies Revenue in Kidney Cancer Drug Business (2015-2020) 10.13.5 Immatics Biotechnologies Recent Development 13.14 Prometheus Laboratories 10.14.1 Prometheus Laboratories Company Details 10.14.2 Prometheus Laboratories Business Overview and Its Total Revenue 10.14.3 Prometheus Laboratories Kidney Cancer Drug Introduction 10.14.4 Prometheus Laboratories Revenue in Kidney Cancer Drug Business (2015-2020) 10.14.5 Prometheus Laboratories Recent Development 13.15 Exelixis 10.15.1 Exelixis Company Details 10.15.2 Exelixis Business Overview and Its Total Revenue 10.15.3 Exelixis Kidney Cancer Drug Introduction 10.15.4 Exelixis Revenue in Kidney Cancer Drug Business (2015-2020) 10.15.5 Exelixis Recent Development 14 Analyst's Viewpoints/Conclusions 15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.2 Data Source 15.2 Disclaimer 15.3 Author Details

Get Free Sample

List of Tables Table 1. Kidney Cancer Drug Key Market Segments Table 2. Key Players Covered: Ranking by Kidney Cancer Drug Revenue Table 3. Ranking of Global Top Kidney Cancer Drug Manufacturers by Revenue (US$ Million) in 2019 Table 4. Global Kidney Cancer Drug Market Size Growth Rate by Type (US$ Million): 2020 VS 2026 Table 5. Key Players of Nexavar (Sorafenib) Table 6. Key Players of Sutent (Sunitinib) Table 7. Key Players of Afinitor (Everolimus) Table 8. Key Players of Votrient (Pazopanib) Table 9. Key Players of Avastin (Bevacizumab) Table 10. Key Players of Inlyta (Axitinib) Table 11. Key Players of Torisel (Temsirolimus) Table 12. Key Players of Proleukin (Aldesleukin) Table 13. Key Players of Other Table 14. COVID-19 Impact Global Market: (Four Kidney Cancer Drug Market Size Forecast Scenarios) Table 15. Opportunities and Trends for Kidney Cancer Drug Players in the COVID-19 Landscape Table 16. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis Table 17. Key Regions/Countries Measures against Covid-19 Impact Table 18. Proposal for Kidney Cancer Drug Players to Combat Covid-19 Impact Table 19. Global Kidney Cancer Drug Market Size Growth by Application (US$ Million): 2020 VS 2026 Table 20. Global Kidney Cancer Drug Market Size by Regions (US$ Million): 2020 VS 2026 Table 21. Global Kidney Cancer Drug Market Size by Regions (2015-2020) (US$ Million) Table 22. Global Kidney Cancer Drug Market Share by Regions (2015-2020) Table 23. Global Kidney Cancer Drug Forecasted Market Size by Regions (2021-2026) (US$ Million) Table 24. Global Kidney Cancer Drug Market Share by Regions (2021-2026) Table 25. Market Top Trends Table 26. Key Drivers: Impact Analysis Table 27. Key Challenges Table 28. Kidney Cancer Drug Market Growth Strategy Table 29. Main Points Interviewed from Key Kidney Cancer Drug Players Table 30. Global Kidney Cancer Drug Revenue by Players (2015-2020) (Million US$) Table 31. Global Kidney Cancer Drug Market Share by Players (2015-2020) Table 32. Global Top Kidney Cancer Drug Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Kidney Cancer Drug as of 2019) Table 33. Global Kidney Cancer Drug by Players Market Concentration Ratio (CR5 and HHI) Table 34. Key Players Headquarters and Area Served Table 35. Key Players Kidney Cancer Drug Product Solution and Service Table 36. Date of Enter into Kidney Cancer Drug Market Table 37. Mergers & Acquisitions, Expansion Plans Table 38. Global Kidney Cancer Drug Market Size by Type (2015-2020) (Million US$) Table 39. Global Kidney Cancer Drug Market Size Share by Type (2015-2020) Table 40. Global Kidney Cancer Drug Revenue Market Share by Type (2021-2026) Table 41. Global Kidney Cancer Drug Market Size Share by Application (2015-2020) Table 42. Global Kidney Cancer Drug Market Size by Application (2015-2020) (Million US$) Table 43. Global Kidney Cancer Drug Market Size Share by Application (2021-2026) Table 44. North America Key Players Kidney Cancer Drug Revenue (2019-2020) (Million US$) Table 45. North America Key Players Kidney Cancer Drug Market Share (2019-2020) Table 46. North America Kidney Cancer Drug Market Size by Type (2015-2020) (Million US$) Table 47. North America Kidney Cancer Drug Market Share by Type (2015-2020) Table 48. North America Kidney Cancer Drug Market Size by Application (2015-2020) (Million US$) Table 49. North America Kidney Cancer Drug Market Share by Application (2015-2020) Table 50. Europe Key Players Kidney Cancer Drug Revenue (2019-2020) (Million US$) Table 51. Europe Key Players Kidney Cancer Drug Market Share (2019-2020) Table 52. Europe Kidney Cancer Drug Market Size by Type (2015-2020) (Million US$) Table 53. Europe Kidney Cancer Drug Market Share by Type (2015-2020) Table 54. Europe Kidney Cancer Drug Market Size by Application (2015-2020) (Million US$) Table 55. Europe Kidney Cancer Drug Market Share by Application (2015-2020) Table 56. China Key Players Kidney Cancer Drug Revenue (2019-2020) (Million US$) Table 57. China Key Players Kidney Cancer Drug Market Share (2019-2020) Table 58. China Kidney Cancer Drug Market Size by Type (2015-2020) (Million US$) Table 59. China Kidney Cancer Drug Market Share by Type (2015-2020) Table 60. China Kidney Cancer Drug Market Size by Application (2015-2020) (Million US$) Table 61. China Kidney Cancer Drug Market Share by Application (2015-2020) Table 62. Japan Key Players Kidney Cancer Drug Revenue (2019-2020) (Million US$) Table 63. Japan Key Players Kidney Cancer Drug Market Share (2019-2020) Table 64. Japan Kidney Cancer Drug Market Size by Type (2015-2020) (Million US$) Table 65. Japan Kidney Cancer Drug Market Share by Type (2015-2020) Table 66. Japan Kidney Cancer Drug Market Size by Application (2015-2020) (Million US$) Table 67. Japan Kidney Cancer Drug Market Share by Application (2015-2020) Table 68. Southeast Asia Key Players Kidney Cancer Drug Revenue (2019-2020) (Million US$) Table 69. Southeast Asia Key Players Kidney Cancer Drug Market Share (2019-2020) Table 70. Southeast Asia Kidney Cancer Drug Market Size by Type (2015-2020) (Million US$) Table 71. Southeast Asia Kidney Cancer Drug Market Share by Type (2015-2020) Table 72. Southeast Asia Kidney Cancer Drug Market Size by Application (2015-2020) (Million US$) Table 73. Southeast Asia Kidney Cancer Drug Market Share by Application (2015-2020) Table 74. India Key Players Kidney Cancer Drug Revenue (2019-2020) (Million US$) Table 75. India Key Players Kidney Cancer Drug Market Share (2019-2020) Table 76. India Kidney Cancer Drug Market Size by Type (2015-2020) (Million US$) Table 77. India Kidney Cancer Drug Market Share by Type (2015-2020) Table 78. India Kidney Cancer Drug Market Size by Application (2015-2020) (Million US$) Table 79. India Kidney Cancer Drug Market Share by Application (2015-2020) Table 80. Central & South America Key Players Kidney Cancer Drug Revenue (2019-2020) (Million US$) Table 81. Central & South America Key Players Kidney Cancer Drug Market Share (2019-2020) Table 82. Central & South America Kidney Cancer Drug Market Size by Type (2015-2020) (Million US$) Table 83. Central & South America Kidney Cancer Drug Market Share by Type (2015-2020) Table 84. Central & South America Kidney Cancer Drug Market Size by Application (2015-2020) (Million US$) Table 85. Central & South America Kidney Cancer Drug Market Share by Application (2015-2020) Table 86. Active Biotech Company Details Table 87. Active Biotech Business Overview Table 88. Active Biotech Product Table 89. Active Biotech Revenue in Kidney Cancer Drug Business (2015-2020) (Million US$) Table 90. Active Biotech Recent Development Table 91. Amgen Company Details Table 92. Amgen Business Overview Table 93. Amgen Product Table 94. Amgen Revenue in Kidney Cancer Drug Business (2015-2020) (Million US$) Table 95. Amgen Recent Development Table 96. Bayer AG Company Details Table 97. Bayer AG Business Overview Table 98. Bayer AG Product Table 99. Bayer AG Revenue in Kidney Cancer Drug Business (2015-2020) (Million US$) Table 100. Bayer AG Recent Development Table 101. Cipla Limited Company Details Table 102. Cipla Limited Business Overview Table 103. Cipla Limited Product Table 104. Cipla Limited Revenue in Kidney Cancer Drug Business (2015-2020) (Million US$) Table 105. Cipla Limited Recent Development Table 106. F. Hoffmann-La Roche Company Details Table 107. F. Hoffmann-La Roche Business Overview Table 108. F. Hoffmann-La Roche Product Table 109. F. Hoffmann-La Roche Revenue in Kidney Cancer Drug Business (2015-2020) (Million US$) Table 110. F. Hoffmann-La Roche Recent Development Table 111. Genentech Company Details Table 112. Genentech Business Overview Table 113. Genentech Product Table 114. Genentech Revenue in Kidney Cancer Drug Business (2015-2020) (Million US$) Table 115. Genentech Recent Development Table 116. Glaxosmithkline PLC Company Details Table 117. Glaxosmithkline PLC Business Overview Table 118. Glaxosmithkline PLC Product Table 119. Glaxosmithkline PLC Revenue in Kidney Cancer Drug Business (2015-2020) (Million US$) Table 120. Glaxosmithkline PLC Recent Development Table 121. Novartis AG Business Overview Table 122. Novartis AG Product Table 123. Novartis AG Company Details Table 124. Novartis AG Revenue in Kidney Cancer Drug Business (2015-2020) (Million US$) Table 125. Novartis AG Recent Development Table 126. Onyx Pharmaceuticals Company Details Table 127. Onyx Pharmaceuticals Business Overview Table 128. Onyx Pharmaceuticals Product Table 129. Onyx Pharmaceuticals Revenue in Kidney Cancer Drug Business (2015-2020) (Million US$) Table 130. Onyx Pharmaceuticals Recent Development Table 131. Pfizer Company Details Table 132. Pfizer Business Overview Table 133. Pfizer Product Table 134. Pfizer Revenue in Kidney Cancer Drug Business (2015-2020) (Million US$) Table 135. Pfizer Recent Development Table 136. Abbott Laboratories Company Details Table 137. Abbott Laboratories Business Overview Table 138. Abbott Laboratories Product Table 139. Abbott Laboratories Revenue in Kidney Cancer Drug Business (2015-2020) (Million US$) Table 140. Abbott Laboratories Recent Development Table 141. Aveo Pharmaceuticals Company Details Table 142. Aveo Pharmaceuticals Business Overview Table 143. Aveo Pharmaceuticals Product Table 144. Aveo Pharmaceuticals Revenue in Kidney Cancer Drug Business (2015-2020) (Million US$) Table 145. Aveo Pharmaceuticals Recent Development Table 146. Immatics Biotechnologies Company Details Table 147. Immatics Biotechnologies Business Overview Table 148. Immatics Biotechnologies Product Table 149. Immatics Biotechnologies Revenue in Kidney Cancer Drug Business (2015-2020) (Million US$) Table 150. Immatics Biotechnologies Recent Development Table 151. Prometheus Laboratories Company Details Table 152. Prometheus Laboratories Business Overview Table 153. Prometheus Laboratories Product Table 154. Prometheus Laboratories Revenue in Kidney Cancer Drug Business (2015-2020) (Million US$) Table 155. Prometheus Laboratories Recent Development Table 156. Exelixis Company Details Table 157. Exelixis Business Overview Table 158. Exelixis Product Table 159. Exelixis Revenue in Kidney Cancer Drug Business (2015-2020) (Million US$) Table 160. Exelixis Recent Development Table 161. Research Programs/Design for This Report Table 162. Key Data Information from Secondary Sources Table 163. Key Data Information from Primary Sources List of Figures Figure 1. Global Kidney Cancer Drug Market Share by Type: 2020 VS 2026 Figure 2. Nexavar (Sorafenib) Features Figure 3. Sutent (Sunitinib) Features Figure 4. Afinitor (Everolimus) Features Figure 5. Votrient (Pazopanib) Features Figure 6. Avastin (Bevacizumab) Features Figure 7. Inlyta (Axitinib) Features Figure 8. Torisel (Temsirolimus) Features Figure 9. Proleukin (Aldesleukin) Features Figure 10. Other Features Figure 11. Global Kidney Cancer Drug Market Share by Application: 2020 VS 2026 Figure 12. Hospitals Case Studies Figure 13. Clinics Case Studies Figure 14. Research Center Case Studies Figure 15. Other Case Studies Figure 16. Kidney Cancer Drug Report Years Considered Figure 17. Global Kidney Cancer Drug Market Size YoY Growth 2015-2026 (US$ Million) Figure 18. Global Kidney Cancer Drug Market Share by Regions: 2020 VS 2026 Figure 19. Global Kidney Cancer Drug Market Share by Regions (2021-2026) Figure 20. Porter's Five Forces Analysis Figure 21. Global Kidney Cancer Drug Market Share by Players in 2019 Figure 22. Global Top Kidney Cancer Drug Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Kidney Cancer Drug as of 2019 Figure 23. The Top 10 and 5 Players Market Share by Kidney Cancer Drug Revenue in 2019 Figure 24. North America Kidney Cancer Drug Market Size YoY Growth (2015-2020) (Million US$) Figure 25. Europe Kidney Cancer Drug Market Size YoY Growth (2015-2020) (Million US$) Figure 26. China Kidney Cancer Drug Market Size YoY Growth (2015-2020) (Million US$) Figure 27. Japan Kidney Cancer Drug Market Size YoY Growth (2015-2020) (Million US$) Figure 28. Southeast Asia Kidney Cancer Drug Market Size YoY Growth (2015-2020) (Million US$) Figure 29. India Kidney Cancer Drug Market Size YoY Growth (2015-2020) (Million US$) Figure 30. Central & South America Kidney Cancer Drug Market Size YoY Growth (2015-2020) (Million US$) Figure 31. Active Biotech Total Revenue (US$ Million): 2019 Compared with 2018 Figure 32. Active Biotech Revenue Growth Rate in Kidney Cancer Drug Business (2015-2020) Figure 33. Amgen Total Revenue (US$ Million): 2019 Compared with 2018 Figure 34. Amgen Revenue Growth Rate in Kidney Cancer Drug Business (2015-2020) Figure 35. Bayer AG Total Revenue (US$ Million): 2019 Compared with 2018 Figure 36. Bayer AG Revenue Growth Rate in Kidney Cancer Drug Business (2015-2020) Figure 37. Cipla Limited Total Revenue (US$ Million): 2019 Compared with 2018 Figure 38. Cipla Limited Revenue Growth Rate in Kidney Cancer Drug Business (2015-2020) Figure 39. F. Hoffmann-La Roche Total Revenue (US$ Million): 2019 Compared with 2018 Figure 40. F. Hoffmann-La Roche Revenue Growth Rate in Kidney Cancer Drug Business (2015-2020) Figure 41. Genentech Total Revenue (US$ Million): 2019 Compared with 2018 Figure 42. Genentech Revenue Growth Rate in Kidney Cancer Drug Business (2015-2020) Figure 43. Glaxosmithkline PLC Total Revenue (US$ Million): 2019 Compared with 2018 Figure 44. Glaxosmithkline PLC Revenue Growth Rate in Kidney Cancer Drug Business (2015-2020) Figure 45. Novartis AG Total Revenue (US$ Million): 2019 Compared with 2018 Figure 46. Novartis AG Revenue Growth Rate in Kidney Cancer Drug Business (2015-2020) Figure 47. Onyx Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018 Figure 48. Onyx Pharmaceuticals Revenue Growth Rate in Kidney Cancer Drug Business (2015-2020) Figure 49. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018 Figure 50. Pfizer Revenue Growth Rate in Kidney Cancer Drug Business (2015-2020) Figure 51. Abbott Laboratories Total Revenue (US$ Million): 2019 Compared with 2018 Figure 52. Abbott Laboratories Revenue Growth Rate in Kidney Cancer Drug Business (2015-2020) Figure 53. Aveo Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018 Figure 54. Aveo Pharmaceuticals Revenue Growth Rate in Kidney Cancer Drug Business (2015-2020) Figure 55. Immatics Biotechnologies Total Revenue (US$ Million): 2019 Compared with 2018 Figure 56. Immatics Biotechnologies Revenue Growth Rate in Kidney Cancer Drug Business (2015-2020) Figure 57. Prometheus Laboratories Total Revenue (US$ Million): 2019 Compared with 2018 Figure 58. Prometheus Laboratories Revenue Growth Rate in Kidney Cancer Drug Business (2015-2020) Figure 59. Exelixis Total Revenue (US$ Million): 2019 Compared with 2018 Figure 60. Exelixis Revenue Growth Rate in Kidney Cancer Drug Business (2015-2020) Figure 61. Bottom-up and Top-down Approaches for This Report Figure 62. Data Triangulation Figure 63. Key Executives Interviewed

Get Free Sample

Related Reports

COVID-19 Impact on Global Kidney Cancer Drug Market Size, Status and Forecast 2020-2026

Global Cushing's Syndrome Treatment Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

Cushing's syndrome involves symptoms such as high blood pressure, abdominal obesity, round red face, a fatty lump between the shoulders, weak muscles and bones, acne, fragile skin and others. Most ...
read more

COVID-19 Impact on Global Kidney Cancer Drug Market Size, Status and Forecast 2020-2026

Global Tyrosine Kinase Inhibitors Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

Tyrosine kinase inhibitors are small molecules that bind to the receptor site of the kinase enzyme available at cell surface. Scope of the Report: The global tyrosine kinase inhibitors market is e ...
read more

COVID-19 Impact on Global Kidney Cancer Drug Market Size, Status and Forecast 2020-2026

Global 2D Chromatography Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

2D chromatography is a type of chromatographic technique in which the injected sample is separated by passing through two different separation stages. This is done by injecting the eluent from the fir ...
read more

COVID-19 Impact on Global Kidney Cancer Drug Market Size, Status and Forecast 2020-2026

Global Astringent Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

Astringent are used as an adjunct or alternative to standard suturing techniques to control bleeding or for wound closure. Scope of the Report: In 2018, North America is expected to account for th ...
read more

COVID-19 Impact on Global Kidney Cancer Drug Market Size, Status and Forecast 2020-2026

Global Disintegrants Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

Disintegrants are agents added to tablet (and some encapsulated) formulations to promote the breakup of the tablet (and capsule “slugs') into smaller fragments in an aqueous environment thereby ...
read more


Choose License Type

Single User - This is a single user license, allowing one specific user access to the product.

Multi User - This is a 1-5 user licence, allowing up to five users have access to the product.

Enterprise User - This is an enterprise license, allowing all employees within your organisation access to the product. The report will be emailed to you.


Cards For Payment

Why Choose us

  • Lowest Price Guarantee
  • We offer the lowest prices for the listed reports
  • Data Security
  • Your data is safe and secure
  • Vast Report Database
  • We have more than 2 Million reports in our database
  • Client Focused
  • Personalized updates and 24*7 support
  • Trusted Source and Quality
  • We only work with reputable partners providing high quality research and support
  • Market Segmentation
  • We provide alternative views of the market to help you identify where the real opportunities lie
  • Bulk Discounts
  • We offer great discounts on purchase of multiple reports

Testimonials

Well structured, the insights they shared with us were very helpful and reliable. Their timely assistance make their services invaluable to us. I would highly recommend them and would definitely use them again in the future if needed.
-VP of a Automotive division in Germany

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements
-Product Manager at US based Manufacturer

Coherent, high-quality, thoroughly-researched reports. We received a very quick response to all our queries which eventually expedited the entire process
-Marketing Manager at a pharma company in Belgium

How To Reach Us

Reach out to our most senior Sales Professional-
Jay Matthews

+1 513 549 5911 (U.S.),
    +44 203 318 2846 (U.K.)
sales@marketresearchvision.com
 

Our Clients






Market Research Vision

About Us


Market Research Vision is a leading market research and market intelligence organization, specializing in research, analytics, and advisory services along with providing business insights & market research reports. Serving as a market research firm, we help our clients in finding: what’s next? We believe in finding creative and innovative solutions through customized and syndicated research reports.
Read More


Contact Us


 
sales@marketresearchvision.com


+1 513 549 5911 (U.S.)
+44 203 318 2846 (U.K.)